Isracann Biosciences, Inc. Isracann Bioscien
Post# of 87083
(Total Views: 395)
Posted On: 05/28/2020 10:34:07 AM
Isracann Biosciences, Inc.
Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ISCNF) aims to capitalize on its fully-funded 230,000 sq. ft. hybrid greenhouse cultivation project and partnership with a late-stage project consisting of about 200,000 sq. ft. of greenhouses located on over 880,000 sq. ft. of agricultural land. The company is also developing European distribution channels while ensuring that its facilities comply with EU GMP regulations.
In April, the company closed a deal to acquire a 50% interest in a joint venture, Cannation Ltd., for a phased partnership with two near-term farm operations located in the Hefer Valley region of Israel. Cannation has an off-take agreement with Focus Medical Herbs Ltd., a licensed medical cannabis producer in Israel, for a three year definitive supply agreement for about 2,600 kilograms of medical cannabis per year.
https://apnews.com/b36e2ba91fa0e53e3724a2c263670049
Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ISCNF) aims to capitalize on its fully-funded 230,000 sq. ft. hybrid greenhouse cultivation project and partnership with a late-stage project consisting of about 200,000 sq. ft. of greenhouses located on over 880,000 sq. ft. of agricultural land. The company is also developing European distribution channels while ensuring that its facilities comply with EU GMP regulations.
In April, the company closed a deal to acquire a 50% interest in a joint venture, Cannation Ltd., for a phased partnership with two near-term farm operations located in the Hefer Valley region of Israel. Cannation has an off-take agreement with Focus Medical Herbs Ltd., a licensed medical cannabis producer in Israel, for a three year definitive supply agreement for about 2,600 kilograms of medical cannabis per year.
https://apnews.com/b36e2ba91fa0e53e3724a2c263670049
(3)
(0)